Michael Pins

9.0k total citations
53 papers, 2.0k citations indexed

About

Michael Pins is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Michael Pins has authored 53 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 21 papers in Molecular Biology. Recurrent topics in Michael Pins's work include Renal cell carcinoma treatment (15 papers), Cancer Genomics and Diagnostics (11 papers) and Renal and related cancers (9 papers). Michael Pins is often cited by papers focused on Renal cell carcinoma treatment (15 papers), Cancer Genomics and Diagnostics (11 papers) and Renal and related cancers (9 papers). Michael Pins collaborates with scholars based in United States, China and Canada. Michael Pins's co-authors include Ximing J. Yang, Chung Lee, Carolyn C. Compton, Kent Lewandrowski, Andrew L. Warshaw, Raymond C. Bergan, David W. Rattner, Jaime A. Rivera, Edward C. Jones and G. Richard Dickersin and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Michael Pins

52 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Pins United States 25 1.1k 891 795 428 418 53 2.0k
Teruhiko Yoshida Japan 24 1.1k 1.0× 1.1k 1.2× 974 1.2× 269 0.6× 464 1.1× 54 2.2k
Pol Specenier Belgium 21 624 0.6× 1.1k 1.2× 542 0.7× 287 0.7× 261 0.6× 84 1.9k
Sebastian Aulmann Germany 31 1.0k 0.9× 910 1.0× 795 1.0× 324 0.8× 667 1.6× 74 2.4k
Elaine T. Lam United States 18 621 0.6× 677 0.8× 648 0.8× 255 0.6× 528 1.3× 119 1.8k
Mária Dudás United States 18 806 0.8× 650 0.7× 822 1.0× 479 1.1× 497 1.2× 22 2.0k
Sherri Z. Millis United States 25 772 0.7× 1.1k 1.3× 852 1.1× 435 1.0× 421 1.0× 93 2.3k
W. Grigioni Italy 24 636 0.6× 725 0.8× 642 0.8× 376 0.9× 604 1.4× 59 2.3k
Mark L. Levitt United States 16 799 0.7× 1.1k 1.2× 464 0.6× 216 0.5× 349 0.8× 43 1.9k
Yoshiyuki Kuwabara Japan 20 996 0.9× 526 0.6× 408 0.5× 371 0.9× 488 1.2× 96 1.8k
Ang Li China 18 652 0.6× 1.5k 1.6× 619 0.8× 335 0.8× 405 1.0× 61 2.0k

Countries citing papers authored by Michael Pins

Since Specialization
Citations

This map shows the geographic impact of Michael Pins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Pins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Pins more than expected).

Fields of papers citing papers by Michael Pins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Pins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Pins. The network helps show where Michael Pins may publish in the future.

Co-authorship network of co-authors of Michael Pins

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Pins. A scholar is included among the top collaborators of Michael Pins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Pins. Michael Pins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jilaveanu, Lucia B., Mäneka Puligandla, Sarah A. Weiss, et al.. (2017). Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805. Clinical Cancer Research. 24(1). 217–223. 24 indexed citations
2.
Pins, Michael, et al.. (2014). Successful Therapy of Rapidly Progressing Bronchiolitis Obliterans in an Adolescent. CHEST Journal. 146(4). 691A–691A. 1 indexed citations
3.
Haas, Naomi B., Xinyi Lin, Judith Manola, et al.. (2011). A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802. Medical Oncology. 29(2). 761–767. 97 indexed citations
4.
Liu, Glenn, Yu‐Hui Chen, Jill Kolesar, et al.. (2011). Eastern Cooperative Oncology Group Phase II Trial of lapatinib in men with biochemically relapsed, androgen dependent prostate cancer. Urologic Oncology Seminars and Original Investigations. 31(2). 211–218. 20 indexed citations
5.
Bhatt, Rupal S., Judith Manola, Anthony J. Bullock, et al.. (2011). Host-mediated changes in patients receiving antiangiogenic therapy for resected RCC.. Journal of Clinical Oncology. 29(15_suppl). 4557–4557. 2 indexed citations
6.
Zhang, Qiang, Brian T. Helfand, Thomas L. Jang, et al.. (2009). Nuclear Factor-κB-Mediated Transforming Growth Factor-β-Induced Expression of Vimentin Is an Independent Predictor of Biochemical Recurrence after Radical Prostatectomy. Clinical Cancer Research. 15(10). 3557–3567. 93 indexed citations
7.
Argiris, Athanassios, Ashley Buchanan, Bruce Brockstein, et al.. (2009). Docetaxel and irinotecan in recurrent or metastatic head and neck cancer. Cancer. 115(19). 4504–4513. 17 indexed citations
8.
Nguyen, Minh M., Scott Eggener, Feng Jiang, et al.. (2009). Suppressive Roles of Calreticulin in Prostate Cancer Growth and Metastasis. American Journal Of Pathology. 175(2). 882–890. 49 indexed citations
9.
Moulder, Stacy L., Hailun Li, Molin Wang, et al.. (2009). A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial. Breast Cancer Research and Treatment. 119(3). 663–671. 33 indexed citations
10.
Ai, Junkui, Jeffrey A. Stern, Scott Eggener, et al.. (2007). Expression, Function of the Human Androgen-Responsive Gene AD11 in Prostate Cancer. Neoplasia. 9(8). 643–651. 33 indexed citations
11.
Xiao, Wuhan, Geoffrey M. Habermacher, Ximing J. Yang, et al.. (2007). U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia. Oncogene. 27(11). 1536–1544. 56 indexed citations
12.
Ding, Yongzeng, Li Xu, Shan Chen, et al.. (2006). Gene profiling of genistein’s effect in men with prostate cancer.. Cancer Research. 66. 1234–1235. 1 indexed citations
13.
Eklund, John, Mark Kozloff, Borko Jovanovic, et al.. (2006). Phase II study of mitoxantrone and ketoconazole for hormone‐refractory prostate cancer. Cancer. 106(11). 2459–2465. 20 indexed citations
14.
Ding, Yongzeng, Li Xu, Borko Jovanovic, et al.. (2006). Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification. Prostate Cancer and Prostatic Diseases. 9(4). 379–391. 16 indexed citations
15.
Argiris, Athanassios, Thomas A. Hensing, Anjana V. Yeldandi, et al.. (2006). Combined Analysis of Molecular and Clinical Predictors of Gefitinib Activity in Advanced Non–Small Cell Lung Cancer: Epidermal Growth Factor Receptor Mutations Do Not Tell the Whole Story. Journal of Thoracic Oncology. 1(1). 52–60. 14 indexed citations
16.
Zhang, Qiang, Thomas L. Jang, Ximing J. Yang, et al.. (2005). Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells. The Prostate. 66(3). 235–247. 19 indexed citations
17.
Yang, Ximing J., Jun Sugimura, Maria Tretiakova, et al.. (2004). Gene expression profiling of renal medullary carcinoma. Cancer. 100(5). 976–985. 58 indexed citations
18.
Jovanovic, Borko, et al.. (2002). Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion. Oncogene. 21(54). 8272–8281. 89 indexed citations
19.
Liu, Yaqing, Edward Kyle, Sajni Patel, et al.. (2001). Prostate cancer chemoprevention agents exhibit selective activity against early stage prostate cancer cells. Prostate Cancer and Prostatic Diseases. 4(2). 81–91. 25 indexed citations
20.
Z’graggen, Kaspar, Jaime A. Rivera, Carolyn C. Compton, et al.. (1997). Prevalence of Activating K-ras Mutations in the Evolutionary Stages of Neoplasia in Intraductal Papillary Mucinous Tumors of the Pancreas. Annals of Surgery. 226(4). 491–500. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teruhiko Yoshida Breakdown of academic impact, for papers by Pol Specenier Breakdown of academic impact, for papers by Sebastian Aulmann Breakdown of academic impact, for papers by Elaine T. Lam Breakdown of academic impact, for papers by Mária Dudás Breakdown of academic impact, for papers by Sherri Z. Millis Breakdown of academic impact, for papers by W. Grigioni Breakdown of academic impact, for papers by Mark L. Levitt Breakdown of academic impact, for papers by Yoshiyuki Kuwabara Breakdown of academic impact, for papers by Ang Li
Rankless by CCL
2026